South America Pharmacogenetic Testing Market to 2032
Overview
The South America Pharmacogenetic Testing Market is expected to reach a 471.62 USD Million by 2032 and is projected to grow at a CAGR of 10.00% from 2025 to 2032.
Revenue, 2024 (USD Million)
271.09
Forecast, 2032 (USD Million)
471.62
CAGR, 2024 - 2032
10.00%
Report Coverage
South America
South America Pharmacogenetic Testing Market 2018-2032 USD Million
South America Pharmacogenetic Testing Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 271.09 USD Million
- Projected Market Size (2032): 471.62 USD Million
- CAGR (2025-2032): 10.00%
Key Findings of South America Pharmacogenetic Testing Market
- The South America Pharmacogenetic Testing Market was valued at 271.09 USD Million in 2024.
- The South America Pharmacogenetic Testing Market is likely to grow at a CAGR of 10.00% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Blood in Sample Segment accounted for the largest share of the market with a revenue of 154.49 USD Million
- The fastest growing segment CYP2C19 in Gene Segment grew Fastest with a CAGR of 13.85% during the forecast period from 2024 to 2032.
South America Pharmacogenetic Testing Market Scope
South America Pharmacogenetic Testing Market Segmentation & Scope
Gene
- Others
- TMPT
- HTR2A/C
- SLC6A4
- D4D4
- DRD3
- ONCOTYPE DX® AND MAMMAPRINT®
- OPRM1
- CYP2D
- HLA-B*5701
- HLA-B*1502
- CYP1A2
- CYP2C9 AND VKORC1
- CYP2D6
- CYP2C19
Type
- Single Gene Tests
- Array-Based Tests
- Whole Exome Sequencing
- Whole Genome Sequencing
Drug
- Over-the-Counter Medications
- Vitamins
- Herbal Supplements
- Recreational Drugs
- Nutraceuticals
- Prescription Drugs
Therapeutic Area
- Others
- Neurology
- Oncology
- Gynecology
- Dermatology
- Immunology & Hypersensitivity
- Endocrinology
- Genomics
- Anesthesiology
- Gastroenterology
- Cardiology
Sample
- Saliva
- Blood
Application
- Drug Regulation
- Drug Development
- Clinical Practice
Distribution Channel
- Direct-to-Customer Services
- Mail-Order Pharmacies
- Retail Pharmacies
- Hospital Pharmacy
End User
- Others
- Research Centres and Academic Institutes
- Pharmaceutical & Biotechnology Companies
- Healthcare Providers
South America Pharmacogenetic Testing Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 271.09 USD Million |
| Market Value in 2032 | 471.62 USD Million |
| CAGR (2025-2032) | 10.00% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Gene,Type,Drug,Therapeutic Area,Sample,Application,Distribution Channel,End User |
Regional Insights:
-
Leading Market (2024-2032): South America, leading in terms of revenue 271.09 USD Million in 2024
- Key Country: Brazil, leading in terms of revenue with value of 147.53 USD Million in 2024.
Segments and Scope
-
South America Pharmacogenetic Testing Market to 2032, By Gene
- CYP2C19 is the largest segment in South America Pharmacogenetic Testing Market to 2032 with a revenue of 44.02 USD Million in the year 2024.
- CYP2C19 is the Fastest growing segment in South America Pharmacogenetic Testing Market to 2032 with a Growth rate of 13.85 % in forecast period 2025-2032.
-
South America Pharmacogenetic Testing Market to 2032, By Type
- Whole Genome Sequencing is the largest segment in South America Pharmacogenetic Testing Market to 2032 with a revenue of 136.81 USD Million in the year 2024.
- Whole Genome Sequencing is the Fastest growing segment in South America Pharmacogenetic Testing Market to 2032 with a Growth rate of 10.51 % in forecast period 2025-2032.
-
South America Pharmacogenetic Testing Market to 2032, By Drug
- Prescription Drugs is the largest segment in South America Pharmacogenetic Testing Market to 2032 with a revenue of 93.87 USD Million in the year 2024.
- Prescription Drugs is the Fastest growing segment in South America Pharmacogenetic Testing Market to 2032 with a Growth rate of 11.07 % in forecast period 2025-2032.
-
South America Pharmacogenetic Testing Market to 2032, By Therapeutic Area
- Cardiology is the largest segment in South America Pharmacogenetic Testing Market to 2032 with a revenue of 54.55 USD Million in the year 2024.
- Cardiology is the Fastest growing segment in South America Pharmacogenetic Testing Market to 2032 with a Growth rate of 13.44 % in forecast period 2025-2032.
-
South America Pharmacogenetic Testing Market to 2032, By Sample
- Blood is the largest segment in South America Pharmacogenetic Testing Market to 2032 with a revenue of 154.49 USD Million in the year 2024.
- Blood is the Fastest growing segment in South America Pharmacogenetic Testing Market to 2032 with a Growth rate of 10.17 % in forecast period 2025-2032.
-
South America Pharmacogenetic Testing Market to 2032, By Application
- Clinical Practice is the largest segment in South America Pharmacogenetic Testing Market to 2032 with a revenue of 129.88 USD Million in the year 2024.
- Clinical Practice is the Fastest growing segment in South America Pharmacogenetic Testing Market to 2032 with a Growth rate of 10.46 % in forecast period 2025-2032.
-
South America Pharmacogenetic Testing Market to 2032, By Distribution Channel
- Hospital Pharmacy is the largest segment in South America Pharmacogenetic Testing Market to 2032 with a revenue of 130.20 USD Million in the year 2024.
- Hospital Pharmacy is the Fastest growing segment in South America Pharmacogenetic Testing Market to 2032 with a Growth rate of 10.53 % in forecast period 2025-2032.
-
South America Pharmacogenetic Testing Market to 2032, By End User
- Healthcare Providers is the largest segment in South America Pharmacogenetic Testing Market to 2032 with a revenue of 117.43 USD Million in the year 2024.
- Healthcare Providers is the Fastest growing segment in South America Pharmacogenetic Testing Market to 2032 with a Growth rate of 10.66 % in forecast period 2025-2032.
South America Pharmacogenetic Testing Market Company Share Analysis
| Company Name |
|
||
| Illumina, Inc. | |||
| Thermo Fisher Scientific Inc. | |||
| QIAGEN | |||
| Sonic Healthcare Limited | |||
| BGI | |||
South America Pharmacogenetic Testing Market Geographical Sales Distribution, 2018-2032 USD Million
South America Pharmacogenetic Testing Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The South America Pharmacogenetic Testing Market is segmented based on Segmentation Gene,Type,Drug,Therapeutic Area,Sample,Application,Distribution Channel,End User.
South America Pharmacogenetic Testing Market was valued at USD 271.09(Revenue in USD Million) in 2021.
South America Pharmacogenetic Testing Market is projected to grow at a CAGR of 10.00% during the forecast period of 2024 to 2032.
The Blood segment is expected to dominate the South America Pharmacogenetic Testing Market, holding a largest market share of 154.49 USD Million in 2024
South America Pharmacogenetic Testing Market Scope
South America Pharmacogenetic Testing Market Segmentation & Scope
Gene
- Others
- TMPT
- HTR2A/C
- SLC6A4
- D4D4
- DRD3
- ONCOTYPE DX® AND MAMMAPRINT®
- OPRM1
- CYP2D
- HLA-B*5701
- HLA-B*1502
- CYP1A2
- CYP2C9 AND VKORC1
- CYP2D6
- CYP2C19
Type
- Single Gene Tests
- Array-Based Tests
- Whole Exome Sequencing
- Whole Genome Sequencing
Drug
- Over-the-Counter Medications
- Vitamins
- Herbal Supplements
- Recreational Drugs
- Nutraceuticals
- Prescription Drugs
Therapeutic Area
- Others
- Neurology
- Oncology
- Gynecology
- Dermatology
- Immunology & Hypersensitivity
- Endocrinology
- Genomics
- Anesthesiology
- Gastroenterology
- Cardiology
Sample
- Saliva
- Blood
Application
- Drug Regulation
- Drug Development
- Clinical Practice
Distribution Channel
- Direct-to-Customer Services
- Mail-Order Pharmacies
- Retail Pharmacies
- Hospital Pharmacy
End User
- Others
- Research Centres and Academic Institutes
- Pharmaceutical & Biotechnology Companies
- Healthcare Providers
Frequently Asked Questions
The South America Pharmacogenetic Testing Market is segmented based on Segmentation Gene,Type,Drug,Therapeutic Area,Sample,Application,Distribution Channel,End User.
South America Pharmacogenetic Testing Market was valued at USD 271.09(Revenue in USD Million) in 2021.
South America Pharmacogenetic Testing Market is projected to grow at a CAGR of 10.00% during the forecast period of 2024 to 2032.
The estimated market value of the South America Pharmacogenetic Testing Market for final year is USD 471.62 (USD Million).
South America Pharmacogenetic Testing Market Company Profiling
Frequently Asked Questions
The South America Pharmacogenetic Testing Market is segmented based on Segmentation Gene,Type,Drug,Therapeutic Area,Sample,Application,Distribution Channel,End User.
South America Pharmacogenetic Testing Market was valued at USD 271.09(Revenue in USD Million) in 2021.
South America Pharmacogenetic Testing Market is projected to grow at a CAGR of 10.00% during the forecast period of 2024 to 2032.
The estimated market value of the South America Pharmacogenetic Testing Market for final year is USD 471.62 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.